The Cidofovir,injection, cataloged under National Stock Number 6505-01-501-0628, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Gilead Sciences Inc. Government technical data includes 1 specification, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-501-0628 |
| Primary Part Number | NDC61958-0101-01 |
| Item Name | Cidofovir,injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Gilead Sciences Inc |
| Status | ACTIVE |
| American Hospital Formulary Service Classification Number | 081800 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NDC61958-0101-01 PRIMARY | Gilead Sciences Inc (USA) |
| Reference | Meaning |
|---|---|
| VISTIDE | 5/1 Secondary reference Gilead Sciences Inc |
| 02-1677 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-501-0628 is a Cidofovir,injection, manufactured by Gilead Sciences Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-501-0628 has 1 manufacturer part number on file: NDC61958-0101-01 (Gilead Sciences Inc).
Key specifications for NDC61958-0101-01: Special Features: SUPPLIED IN A CLEAR GLASS VIAL, EACH CONTAINING 375 MG OF ANHYDROUS CIDOFOVIR IN 5 ML AQUEOUS SOLUTION AT A CONCENTRAION OF 75 MG/ML; STERILE; SINGLE DOSE VIAL; PRESERVATIVE FREE; INTRAVENOUS USE ONLY; STORE AT CONTROLLED ROOM TEMPERATURE 20 TO 25 DEGREE C (68 TO 77 DEGREES F); Part Name Assigned by Controlling Agency: CIDOFOVIR INJECTION 375MG ANHYDROUS 5ML AQUEOUS CONCENTRATION 75MG/MLVIAL; End Item Identification: FOR THE TREATMENT OF CYTOMEGALOVIRUS (CMV) RETINITIS IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYDROME (AIDS); American Hospital Formulary Service Classification Number: 081800. 1 specification is documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.